These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3754172)

  • 1. How common is diabetic nephropathy?
    Daggett P
    Br J Hosp Med; 1986 Jan; 35(1):52-6. PubMed ID: 3754172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney function, blood pressure and weight behavior in long-term diabetic patients].
    Zimmermann K; Schneider H
    Z Gesamte Inn Med; 1986 May; 41(9):264-7. PubMed ID: 3727650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kidney function in diabetic patients with diabetes of a duration less than 15 years].
    Zimmermann K; Schneider H
    Z Urol Nephrol; 1985 Sep; 78(9):505-10. PubMed ID: 4072455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How common is diabetic nephropathy?
    Gill GV
    Diabetes Res; 1989 Apr; 10(4):197-8. PubMed ID: 2612113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of proteinuria as a marker of nephropathy in type 2 diabetes mellitus.
    Aryal M; Jha B
    Nepal Med Coll J; 2006 Dec; 8(4):250-3. PubMed ID: 17357643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan.
    Lin CH; Yang WC; Tsai ST; Tung TH; Chou P
    Diabetes Res Clin Pract; 2007 Mar; 75(3):306-12. PubMed ID: 16891031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematocrit, urea and gender: the Hematocrit, Urea and GEnder formula for prognosing progressive renal failure in diabetic nephropathy.
    Robles NR; Ferreira F; Martinez-Gallardo R; Alvarez Gregori J; Sanchez-Casado E; Cubero JJ; Macias J
    Eur J Intern Med; 2012 Apr; 23(3):283-6. PubMed ID: 22385889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Demography and effects of chronic renal insufficiency in Ile-de-France].
    Jungers P; Giraud E; Chauveau P; Geffriaud-Ricouard C; Man NK; Altman JJ; Jacobs C; Grünfeld JP
    Nephrologie; 1996; 17(8):429-34. PubMed ID: 9036365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.
    Biesenbach G; Grafinger P; Janko O; Zazgornik J
    Clin Nephrol; 1997 Sep; 48(3):146-50. PubMed ID: 9342485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA; Materson BJ; Reda DJ; Hamburger RJ; Williams DW; Smith MH
    Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of diabetic renal disease. A follow-up study of a series of renal biopsies.
    Watkins PJ; Blainey JD; Brewer DB; Fitzgerald MG; Malins JM; O'Sullivan DJ; Pinto JA
    Q J Med; 1972 Oct; 41(164):437-56. PubMed ID: 4564622
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension and nephrotoxicity in the rate of decline in kidney function in diabetic nephropathy.
    Aubia J; Hojman L; Chine M; Lloveras J; Masramon J; Llorach I; Cuevas X; Puig JM
    Clin Nephrol; 1987 Jan; 27(1):15-20. PubMed ID: 3815904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000.
    Rychlík I; Jancová E; Tesar V; Kolsky A; Lácha J; Stejskal J; Stejskalová A; Dusek J; Herout V
    Nephrol Dial Transplant; 2004 Dec; 19(12):3040-9. PubMed ID: 15507479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy].
    Parving HH; Brenner BM; Cooper ME; de Zeeuw D; Keane WF; Mitch WE; Remuzzi G; Snapinn SM; Zhang Z; Shahinfar S
    Ugeskr Laeger; 2001 Oct; 163(40):5514-9. PubMed ID: 11601117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease.
    Morita S; Fukuhara S; Akizawa T; Asano Y; Koshikawa S; Koide K; Kurokawa K
    Ther Apher Dial; 2006 Feb; 10(1):72-7. PubMed ID: 16556140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland.
    Tryggvason G; Indridason OS; Thorsson AV; Hreidarsson AB; Palsson R
    Diabet Med; 2005 Feb; 22(2):182-7. PubMed ID: 15660736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.